Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 1
2006 2
2007 3
2008 1
2009 1
2011 2
2012 5
2013 3
2014 1
2015 2
2016 2
2017 3
2018 1
2019 3
2020 5
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Vaginal oestrogen therapy after breast cancer: is it safe?
Ponzone R, Biglia N, Jacomuzzi ME, Maggiorotto F, Mariani L, Sismondi P. Ponzone R, et al. Among authors: maggiorotto f. Eur J Cancer. 2005 Nov;41(17):2673-81. doi: 10.1016/j.ejca.2005.07.015. Epub 2005 Oct 18. Eur J Cancer. 2005. PMID: 16239103 Review.
MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer.
Petrelli A, Bellomo SE, Sarotto I, Kubatzki F, Sgandurra P, Maggiorotto F, Di Virgilio MR, Ponzone R, Geuna E, Galizia D, Nuzzo AM, Medico E, Miglio U, Berrino E, Venesio T, Ribisi S, Provero P, Sapino A, Giordano S, Montemurro F. Petrelli A, et al. Among authors: maggiorotto f. ESMO Open. 2020 Oct;5(5):e000937. doi: 10.1136/esmoopen-2020-000937. ESMO Open. 2020. PMID: 33122354 Free PMC article.
Cytoreductive Surgery for Heavily Pre-Treated, Platinum-Resistant Epithelial Ovarian Carcinoma: A Two-Center Retrospective Experience.
Tuninetti V, Di Napoli M, Ghisoni E, Maggiorotto F, Robella M, Scotto G, Giannone G, Turinetto M, Siatis D, Ponzone R, Vaira M, De Simone M, Scaffa C, Pignata S, Greggi S, Di Maio M, Valabrega G. Tuninetti V, et al. Among authors: maggiorotto f. Cancers (Basel). 2020 Aug 10;12(8):2239. doi: 10.3390/cancers12082239. Cancers (Basel). 2020. PMID: 32785193 Free PMC article.
Characteristics and outcome of BRCA mutated epithelial ovarian cancer patients in Italy: A retrospective multicenter study (MITO 21).
Artioli G, Giannone G, Valabrega G, Maggiorotto F, Genta S, Pignata S, Lorusso D, Cormio G, Scalone S, Nicoletto MO, Greco F, Rossi E, Spagnoletti I, De Giorgi U, Orditura M, Mosconi AM, Kardhashi A, Bogliolo S, Borgato L. Artioli G, et al. Among authors: maggiorotto f. Gynecol Oncol. 2021 Jun;161(3):755-761. doi: 10.1016/j.ygyno.2021.04.014. Epub 2021 Apr 20. Gynecol Oncol. 2021. PMID: 33888336 Free article.
Androgen receptor status predicts development of brain metastases in ovarian cancers.
Mittica G, Senetta R, Scotto G, Aglietta M, Maggiorotto F, Ghisoni E, Genta S, Boldorini R, Manini C, Morra I, Buosi R, Sapino A, Cassoni P, Valabrega G. Mittica G, et al. Among authors: maggiorotto f. Oncotarget. 2017 Jun 20;8(25):41143-41153. doi: 10.18632/oncotarget.17068. Oncotarget. 2017. PMID: 28467804 Free PMC article.
33 results